Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Circulating Tumor Cells Provide Current Disease Status

By LabMedica International staff writers
Posted on 11 Oct 2010
Circulating tumor cells (CTCs) may be a promising alternative to biopsies and a noninvasive source of tumor materials for biomarker assessment.

The capture efficiency of two biochip platforms for CTCs was tested using whole blood spiked with tumor cell lines to detect biomarkers such as epidermal growth factor receptor (EGFR) protein expression from patients with lung cancer and human epidermal growth factor receptor 2 (HER2) expression or amplification in patients with metastatic breast cancer. More...


The blood tests were performed on the Veridex CellSearch platform, (Raritan, NJ, USA), which has built in ready-to-use ferrofluid-based capture reagent and immunofluorescent reagents. Under the tested conditions, this platform and the newer biochip platforms were equally efficient, but capture efficiency was dependent on epithelial cell adhesion molecule (EpCAM) expression.

It was reported that captured CTCs were amenable to biomarker analyses such as HER2 status, quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) for breast cancer-subtype markers. The captured CTCs were useful in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation detection and EGFR staining by immunofluorescence. In patients with HER2-positive breast cancer, HER2 status in CTCs and tumor tissue generally correlated well. However, in one patient subset, HER2 status changed from the primary tumor at diagnosis. This finding indicates that in some cases, CTCs may offer a real-time view of a patient's biomarker status that is different from diagnostic tissue. The findings were presented at the Fourth American Association for Cancer Research's International Conference on Molecular Diagnostics in Cancer Therapeutic Development that was held during September 23–27, 2010, in Denver (CO, USA).

Siminder Kaur Atwal, Ph.D., a scientist at Genentech, (South San Francisco, CA, USA), said, "The basic idea is that CTCs can provide real-time information about a patient's current disease state, acting as a 'liquid biopsy.' They are much less invasive than tumor biopsies because they can be detected from a blood draw and do not require surgical intervention." Future studies will focus on evaluating different detection and capture methods with a particular emphasis on tumor types with a low EpCAM expression.

Related Links:

Veridex
Genentech



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.